Related by context. All words. (Click for frequent words.) 76 R#/MEM # 75 alvespimycin 75 Phase Ib study 75 Panzem R 75 CR# vcMMAE 75 ganetespib 75 forodesine 75 tanespimycin 75 PEG SN# 74 evaluating tivozanib 74 Archexin 74 PXD# 74 tezampanel 74 pertuzumab 74 OXi# 73 HGS ETR1 73 XmAb# 73 PRTX 73 YONDELIS 73 Phase IIb trials 73 Phase Ib 73 Phase Ib clinical 73 oral prodrug 73 PD LID 73 Phase 1b trial 73 PSMA ADC 72 ISIS # 72 sapacitabine 72 lintuzumab 72 Xanafide 72 Phase 2a trial 72 MAGE A3 ASCI 72 Bortezomib 72 PEG PAL 72 Azedra 72 phase IIb trial 72 favorable pharmacokinetic profile 72 phase IIb clinical 72 vidofludimus 72 IMA# 72 MGCD# [001] 72 pomalidomide 72 orally administered inhibitor 72 KNS # 72 phase IIa 72 phase IIa clinical 72 oral ridaforolimus 72 Phenoptin 72 Laquinimod 72 Sym# 72 Alocrest 72 Symadex 71 HQK 71 Cloretazine R VNP#M 71 Bezielle 71 CCX# 71 teriflunomide 71 decitabine 71 Omacetaxine 71 Ocrelizumab 71 huC# DM4 71 Androxal TM 71 HGS ETR2 71 GRN#L 71 Panzem R NCD 71 elacytarabine 71 Phase IIa trials 71 cMET 71 Traficet EN 71 BAY #-# 71 mGluR5 NAM 71 HuMax CD4 71 PEG Interferon lambda 71 CCR5 mAb 71 mertansine 71 elotuzumab 71 Phase #b/#a 71 TACI Ig 71 CA4P 71 deforolimus 71 Cloretazine 71 BCX# 71 registrational trial 71 PRT# 71 Phase Ib II 71 ATL# [001] 71 RDEA# 71 enzastaurin 71 CoFactor 71 EndoTAG TM -1 71 LY# [003] 71 axitinib 71 nitazoxanide 71 PLK1 SNALP 71 CTAP# Capsules 71 custirsen 71 Cloretazine ® 71 Chemophase 71 baminercept 70 GALNS 70 Phase 1b 70 HGS# 70 HuMax EGFr 70 oral FTY# 70 PSN# [002] 70 ELACYT 70 torezolid phosphate 70 Phase 2a 70 metaglidasen 70 HuLuc# 70 Golimumab 70 TBC# 70 sorafenib tablets 70 IMC A# 70 Phase 2b Clinical Trial 70 Phase IIa trial 70 Phase #b/#a clinical 70 IL# PE#QQR 70 CIMZIA TM 70 ApoB SNALP 70 TELINTRA 70 MERLIN TIMI 70 KRN# 70 Phase IIIb clinical 70 GAMMAGARD 70 davunetide intranasal AL 70 Phase IIB 70 Lenocta 70 IIa trial 70 talactoferrin 70 Phase #/#a trial 70 oral picoplatin 70 depsipeptide 70 trastuzumab Herceptin R 70 Triolex 70 Plicera 70 Tasimelteon 70 Dapagliflozin 70 Aflibercept 70 AEG# 70 Phase 1a clinical 70 Asentar 70 OncoVEX GM CSF 70 TRO# 70 Imprime PGG 70 ataluren 70 Ceflatonin 70 neratinib 70 cannabinor 70 LEP ETU 70 trastuzumab DM1 T DM1 70 docetaxel Taxotere R 70 alemtuzumab Campath 70 MEK inhibitor 70 RGB # 70 TG# [003] 70 Virulizin ® 70 huN# DM1 70 ProSavin 70 Tezampanel 70 urocortin 2 69 obatoclax 69 PS# [001] 69 novel VDA molecule 69 APTIVUS 69 RhuDex ® 69 ZYBRESTAT 69 BRIM2 69 CRx 69 OvaRex R 69 AQ4N 69 CRLX# 69 Phase 2a clinical 69 Vicriviroc 69 MGd 69 IRX 2 69 Elagolix 69 safinamide 69 diabetic neuropathic pain 69 Personalized Immunotherapy 69 Phase 2a clinical trials 69 phase Ib 69 fosbretabulin 69 Aurexis 69 glufosfamide 69 dacetuzumab 69 QLT# 69 pharmacodynamic PD 69 ruxolitinib 69 LibiGel ® 69 Fx #A 69 PDE4 inhibitor 69 Troxatyl 69 metastatic castration resistant 69 ZOLINZA 69 low dose cytarabine 69 virus HCV protease inhibitor 69 TPI ASM8 69 AP# [003] 69 Proxinium TM 69 Phase IIa clinical 69 entinostat 69 Phase IIb clinical trials 69 Mipomersen 69 TMC# [002] 69 TLK# 69 CEQ# 69 Amigal 69 RG# [001] 69 ENMD # 69 phase IIb 69 velafermin 69 Phase 2b trial 69 nucleoside analog 69 LymphoStat B 69 Glufosfamide 69 Zemplar Capsules 69 Quinamed 69 Factor VIIa 69 Fibrillex TM 69 ongoing Phase 1b 69 non nucleoside inhibitor 69 budesonide foam 69 pralatrexate 69 Vitaxin 69 FOLFOX6 chemotherapy regimen 69 sunitinib malate 69 HDAC Inhibitor 69 AZILECT R 69 nonclinical studies 69 NGX# 69 laquinimod 69 mapatumumab 69 PRX # 69 Phase #b/#a trial 69 riociguat 69 Phase 1a 69 GLP toxicology studies 69 AEGR 69 Aplidin 68 UPLYSO 68 JAK inhibitor 68 VNP#M 68 Ophena TM 68 Genz # 68 paclitaxel Taxol ® 68 Dasatinib 68 CIMZIA ™ 68 INCB# [002] 68 Panzem 68 Aliskiren 68 elvitegravir 68 sargramostim 68 phase 2a 68 Elotuzumab 68 SNT MC# 68 thymalfasin 68 BZL# 68 antibody MAb 68 Pimavanserin 68 EFAPROXYN 68 refractory chronic lymphocytic 68 Romidepsin 68 JVRS 68 angiogenesis inhibitor 68 Zenvia ™ 68 dextromethorphan quinidine 68 Campath alemtuzumab 68 p# biomarker 68 Seliciclib 68 histone deacetylase HDAC inhibitor 68 protein kinase inhibitor 68 Capesaris 68 metastatic hormone refractory 68 ELND# 68 vosaroxin 68 OMP #M# 68 FOLOTYN ® 68 pan HDAC inhibitor 68 investigational humanized monoclonal antibody 68 vorinostat 68 PROSTVAC VF 68 lomitapide 68 Phase III Pivotal 68 inhibitor RG# 68 Amplimexon 68 SRT# [003] 68 anti leukemic 68 Annamycin 68 liposomal formulation 68 JAK2 inhibitor 68 Tanespimycin 68 Zerenex 68 Pivotal Phase 68 GSK# [001] 68 Reverset 68 ocrelizumab 68 bardoxolone methyl 68 Carfilzomib 68 NVA# 68 APOPTONE 68 otelixizumab 68 Tesetaxel 68 EOquin TM 68 ACZ# 68 CBLC# 68 HuMax CD# 68 ixabepilone 68 Hyphanox 68 Azedra TM 68 Talabostat 68 Trofex 68 TYZEKA 68 ISENTRESS 68 pharmacokinetic PK study 68 iniparib 68 HCD# [002] 68 selective androgen receptor modulator 68 eniluracil 68 relapsed MM 68 ganaxolone 68 TRIOLEX 68 SAR# [004] 68 PI3K/Akt pathway inhibitor 68 romidepsin 68 Pivotal Phase III 68 RAPTIVA 68 ORENCIA R 68 evaluating satraplatin 68 novel histone deacetylase 68 Amrubicin 68 aflibercept 68 JAK inhibitors 68 AMD# [003] 68 radiation sensitizer 68 phase IIb study 68 Phase 2b study 68 lesinurad 68 Daclizumab 68 selective modulator 68 Gemzar ® 68 S/GSK# 68 Phase Ib IIa 68 refractory gout 68 ponatinib 68 Meets Primary Endpoint 68 pharmacokinetic PK 68 Perifosine 68 IAP inhibitors 68 TRX1 68 Voreloxin 68 TELCYTA 68 Phase 2b clinical trials 68 Alzhemed TM 68 BRIM3 68 Omnitarg 68 AeroLEF TM 68 Allovectin 7 R 68 Apoptone 68 atacicept 68 investigational monoclonal antibody 68 Icatibant 68 celgosivir 68 erlotinib Tarceva ® 68 farletuzumab 68 aplindore 68 Tyrima 68 Randomized Phase 68 Aplidin R 67 HER2 positive metastatic breast 67 adecatumumab 67 rALLy clinical trial 67 EndoTAGTM 1 67 rNAPc2 67 Intravenous CP 67 LAF# 67 taxane refractory 67 NOX E# 67 MYCAMINE 67 CD# CEA 67 ONCONASE R 67 CCR5 antagonist 67 zanolimumab 67 Prestara 67 lumiliximab 67 Serdaxin 67 evaluating mipomersen 67 galiximab 67 tramiprosate Alzhemed TM 67 Xelox 67 vicriviroc 67 volociximab 67 Tarceva TM 67 XYOTAX TM 67 SCH # 67 Pralatrexate 67 ADAGIO study 67 nucleotide analog 67 initiate Phase 1b 67 OncoVEX 67 JAK1 67 perifosine 67 ALN PCS 67 IMC #B 67 oxaliplatin Eloxatin 67 GRN# 67 placebo controlled Phase III 67 pegylated liposomal doxorubicin 67 Onrigin 67 MDV# 67 Phase 2b clinical 67 registrational 67 Bicifadine 67 clevidipine 67 radezolid 67 dosing cohort 67 tesetaxel 67 teduglutide 67 canakinumab 67 Vilazodone 67 Phase 1b clinical trials 67 Allovectin 7 67 Sapacitabine 67 MNTX 67 PROSTVAC TM 67 placebo controlled clinical 67 ToGA 67 sorafenib Nexavar 67 compound INCB# 67 Phase IIb Clinical Trial 67 Vandetanib 67 brivaracetam 67 CYT# 67 Phase IIb Trial 67 dexpramipexole 67 MEK inhibitors 67 Alemtuzumab 67 pharmacokinetic PK profile 67 bardoxolone 67 Phase Ib clinical trials 67 thalidomide Thalomid 67 targeting CD# 67 trodusquemine 67 BRAF inhibitor 67 preclinical efficacy 67 SPRYCEL ® 67 APTIVUS r 67 lintuzumab SGN 67 PhG alpha 1 67 HCV protease inhibitor 67 opioid induced bowel dysfunction 67 bosutinib 67 TOLAMBA 67 GAP #B# 67 tezampanel NGX# 67 relapsed refractory multiple myeloma 67 talabostat 67 gefitinib Iressa 67 Cethromycin 67 vascular disrupting agent 67 adalimumab Humira 67 LymphoStat B belimumab 67 cilengitide 67 Panitumumab 67 lapatinib Tykerb 67 dirucotide 67 dose cohort 67 MYDICAR ® 67 hour bronchodilation 67 Hsp# Inhibitor 67 Pertuzumab 67 INCB# [003] 67 orally bioavailable 67 Phase III Clinical Trial 67 Phase 1b clinical 67 anti EGFR antibody 67 Telintra 67 visilizumab 67 Boceprevir 67 CRMD# 67 picoplatin 67 Forodesine HCl 67 Trastuzumab 67 NLX P# 67 orally dosed 67 daclizumab 67 investigational protease inhibitor 67 DU #b 67 Antiangiogenic 67 Phase Ia 67 HspE7 67 TKM ApoB 67 SUCCEED trial 67 anticancer compound 67 maximally tolerated dose 67 investigational compound 67 MEK Inhibitor 67 AzaSite Plus 67 lenalidomide Revlimid R 67 Aryplase 67 Microplasmin 67 Locteron 67 OHR/AVR# 67 DCCR 67 OMNARIS HFA 67 GW# [003] 67 Arikace 67 Gleevec resistant 67 Phase IIb clinical 67 Tesmilifene 67 RhuDex 67 GLYX 67 ALN TTR 67 leading oral taxane 67 docetaxel chemotherapy 67 mGluR2 NAM 67 CYT# potent vascular disrupting 67 Abiraterone acetate 67 Jevtana 67 ATL/TV# 67 ProLindac 67 formerly LymphoStat B 67 Fodosine 67 AAG geldanamycin analog 67 MyVax R 67 CYC# 67 tolvaptan 67 CanAg 67 rilonacept 67 Telbivudine 67 relapsed multiple myeloma 67 R#/MEM 67 CCR9 antagonist 67 Rebif ® 67 FTY# 67 Clolar ® 67 PRECISE trial 67 vascular disrupting agents 67 PROVENGE sipuleucel T 67 Randomized Double blind 67 Ambrisentan 67 Phase #/#a 67 OvaRex ® MAb 67 BNC# 67 DermaVir Patch 67 voreloxin 67 Genasense ® oblimersen 66 MKC# MKC# PP 66 Safinamide 66 Revlimid lenalidomide 66 dasatinib Sprycel 66 AVE# 66 sitaxsentan 66 oblimersen 66 CORT # 66 INT# [002] 66 AVONEX ® 66 Tamibarotene 66 Blinatumomab 66 midstage trials 66 metastatic renal cell 66 delafloxacin 66 proteasome inhibitor 66 CB2 selective receptor agonist 66 Ostarine 66 viral kinetics 66 Phase IIa 66 Triapine R 66 Elesclomol 66 Zybrestat 66 LymphoStat B TM 66 bortezomib Velcade 66 ularitide 66 eprotirome 66 Civacir 66 Natalizumab 66 integrase inhibitor 66 hyperphenylalaninemia HPA due 66 VAPRISOL 66 Phase 2a Clinical Trial 66 preclinically 66 Allovectin 7 ® 66 telomerase therapeutic 66 MAP# 66 elvucitabine 66 #ME# 66 eltrombopag 66 docetaxel Taxotere ® 66 Squalamine 66 odanacatib 66 Ozarelix 66 trastuzumab emtansine T DM1 66 ® natalizumab 66 tafamidis 66 methylnaltrexone 66 protease inhibitor PI 66 EOquin 66 demonstrated antitumor activity 66 targeted radiotherapeutic 66 telaprevir VX 66 IDX# 66 oral salmon calcitonin 66 corticosteroid dexamethasone 66 Leukine 66 QVA# 66 MGCD# [002] 66 isoform selective 66 omega interferon 66 Inhalation Solution 66 Zolinza 66 leukemia AML 66 Azixa 66 LCP Tacro 66 Myelodysplastic Syndrome MDS 66 Valortim 66 eliglustat tartrate 66 Zenvia TM 66 GMX# 66 CINQUIL 66 Tarvacin TM 66 Zoraxel 66 Hepatocellular Carcinoma HCC 66 pediatric acute lymphoblastic 66 alvimopan 66 interferon alfa 66 tubulin inhibitor 66 TOCOSOL Paclitaxel 66 intranasal formulation 66 CANCIDAS 66 Tarvacin 66 PNP inhibitor 66 Cimzia R 66 hA# 66 sipuleucel T 66 Virulizin R 66 alfa 2a 66 lorvotuzumab mertansine 66 beta 1a 66 RLY# 66 ulimorelin 66 Dalbavancin 66 refractory AML 66 DXL# 66 Marqibo 66 Solazed TM 66 tocilizumab 66 targeted antifolate 66 Interferon Beta 66 tesmilifene 66 ALN TTR# 66 Interferon alpha 66 tolevamer 66 multicenter Phase II 66 Onconase 66 Aptivus ® 66 randomized Phase 2b 66 Altastaph 66 Synavive 66 SABCS 66 BYETTA ® 66 BrachySil TM 66 bevacizumab Avastin ® 66 GLPG# 66 NXL# 66 PANVAC VF 66 seliciclib CYC# 66 abiraterone acetate 66 dose escalation Phase 66 MOZOBIL 66 nalbuphine ER 66 Pegasys ® 66 Anavex #-# 66 Degarelix 66 NEUVENGE 66 MAXY G# 66 Thiarabine 66 ThGRF 66 azilsartan medoxomil 66 trastuzumab DM1 66 preclinical pharmacokinetic 66 OncoGel 66 6R BH4 66 Tekamlo 66 bendamustine 66 atrasentan 66 systemically administered 66 AGILECT R 66 Diamyd ® 66 belinostat 66 Velcade bortezomib 66 ThermoDox R 66 milatuzumab 66 ACAPODENE 66 elesclomol 66 reslizumab 66 cediranib 66 NeuroVax TM 66 receptor tyrosine kinase inhibitor 66 Omacetaxine mepesuccinate 66 octreotide implant 66 castration resistant prostate cancer 66 DP b# 66 tasocitinib 66 investigational therapies 66 BARACLUDE R 66 trastuzumab Herceptin 66 DDP# 66 Epratuzumab 66 ALN VSP 66 VEGF Trap 66 Campath ® 66 pemetrexed Alimta 66 DAVANAT 66 PKC# 66 mRCC 66 albiglutide 66 clinical pharmacology studies 66 Stedivaze 66 antitumor activity 66 preclinical studies 66 BENLYSTA TM 66 relapsed leukemia 66 valopicitabine 66 ANG# 66 triphendiol 66 Combination REOLYSIN R 66 docetaxel Taxotere 66 ara C 66 JAK Inhibitor 66 Debio 66 glatiramer 66 Investigational Compound 66 Achieves Primary Endpoint 66 TREANDA 66 INC# 66 dosing cohorts 66 CDP# 66 eosinophilic asthma 66 efaproxiral 66 Phase 2b Trial 66 Glybera 66 tgAAC# 66 antiviral efficacy 66 Pafuramidine 66 HCV protease inhibitors 66 pharmacodynamic properties 66 Elvitegravir 66 5 HT6 receptor 66 SNT-MC#/idebenone 66 Cetrorelix 66 Saxagliptin 66 thetreatment 66 Naproxcinod 66 omacetaxine mepesuccinate 66 LBH# 66 CDK inhibitor 66 Bafetinib 66 Targretin 66 Granulocyte Colony Stimulating Factor 66 IMGN# 66 Cethrin 66 Perforomist ™ Inhalation Solution 66 Saforis 66 K ras mutations 65 ACTEMRA TM 65 ARIKACE 65 mGluR2 positive 65 IPL# 65 ruboxistaurin 65 systemic anaplastic large 65 REOLYSIN ® 65 HGS ETR1 mapatumumab 65 Antiviral Activity 65 Tovaxin TM 65 MORAb 65 Interferon beta 1a 65 Valopicitabine 65 AZILECT ® 65 Catena ® 65 Phase IIb 65 SIRT1 activators 65 GVAX ® 65 L BLP# 65 indibulin 65 oral deforolimus 65 Vidaza azacitidine 65 ALGRX 65 aclidinium 65 PHX# 65 ORE# 65 PrevOnco ™ 65 dose cohorts 65 interferon gamma 1b 65 AVN# [001] 65 bortezomib Velcade R 65 SYN# 65 Ceflatonin R 65 Naive Patients 65 Octreolin 65 blinatumomab 65 Proellex TM 65 Dacogen injection 65 Aurora Kinase 65 Thiovir 65 Pivotal Study 65 AZT zidovudine Retrovir 65 Xeloda ® 65 Viramidine 65 lymphoid malignancies 65 Phase III confirmatory 65 R sorafenib tablets 65 metformin sulfonylurea 65 rindopepimut 65 Presents Preclinical 65 CIMZIA TM certolizumab pegol 65 ospemifene 65 Neuradiab 65 palifosfamide 65 CGEN # 65 E1 INT TM 65 ISTODAX 65 CLORETAZINE TM VNP#M 65 tolerability profiles 65 rasagiline tablets 65 multiple ascending dose 65 tenofovir emtricitabine 65 seliciclib 65 Nexavar ® 65 catheter occlusion 65 ANYARA 65 posaconazole 65 MET amplification 65 ascending dose 65 imetelstat 65 cetuximab Erbitux ® 65 mGluR5 negative 65 Zorbtive TM 65 long acting muscarinic 65 proteasome inhibitor bortezomib 65 allosteric modulator NAM 65 Rigel R# 65 LY# [002] 65 RAV# 65 esophageal candidiasis 65 Darusentan 65 ORENCIA ® 65 Belimumab 65 FOLPI 65 confirmatory Phase III 65 Deforolimus 65 Phase III Clinical Trials 65 immune modulating 65 PDE# inhibitors 65 TYKERB 65 immunomodulatory therapy 65 ICA # 65 standard chemotherapy regimen 65 generation purine nucleoside 65 liprotamase 65 cetuximab Erbitux 65 XL# [003] 65 lenalidomide dexamethasone 65 XL# anticancer compounds 65 Fabry Disease 65 ZFP Therapeutic 65 oral methylnaltrexone 65 Nanobody 65 rALLy 65 crizotinib PF # 65 Urocortin 2 65 midstage clinical 65 rALLy trial 65 ORMD 65 Genasense ® 65 BARACLUDE ® 65 CCX# B 65 azacitidine 65 cell lymphoma CTCL 65 investigational HCV polymerase 65 HCV protease 65 Ceplene/IL-2 65 placebo controlled Phase 65 EGS# 65 cancer cachexia 65 Enzastaurin 65 uric acid lowering 65 XL# SAR# 65 estramustine 65 Actilon 65 Antitumor Activity 65 alagebrium 65 ritonavir boosted 65 GFT# 65 Pegasys plus Copegus 65 generation Hsp# inhibitor 65 assessing T DM1 65 pioglitazone HCl 65 Pazopanib 65 PF # [002] 65 ASONEP 65 Vion Pharmaceuticals 65 PEGPH# 65 HDL Selective Delipidation 65 Corlux 65 StemEx 65 Muraglitazar 65 NV1FGF 65 SERMs 65 androgen independent 65 REGN# 65 Decitabine 65 administered subcutaneously 65 Denufosol 65 heavily pretreated 65 severe hypercholesterolemia 65 temsirolimus 65 Cannabinor 65 somatostatin analogue 65 Immunotherapeutic 65 MAXY alpha 65 PEGylated interferon beta 1a 65 Palifosfamide 65 Exelixis compounds 65 randomized Phase IIb 65 lupus nephritis 65 Protexia ® 65 Lixivaptan 65 humanized anti 65 MEK inhibitor RDEA# 65 Exherin TM 65 BCR ABL inhibitor 65 immunomodulatory 65 Solulin 65 cystinosis patients 65 low dose ritonavir 65 Maribavir 65 oral renin inhibitor 65 efalizumab 65 Varespladib 65 vemurafenib 65 REMUNE R 65 ANAVEX #-# [001] 65 pegylated interferons 65 Soliris eculizumab 65 Valortim R 65 optimal dosing regimens 65 PEGylated interferon 65 Taxotere ® 65 LE DT 65 aleglitazar 65 MYDICAR 65 IMiDs R 65 PDX pralatrexate 65 CCR9 65 phase Ib clinical 65 ARIKACE ™ 65 anti amnesic 65 carfilzomib 65 IFN α 65 hyaluronidase enzyme 65 Xcellerated T Cells 65 EZN 65 ALN RSV# 65 Pradefovir 65 polymerase inhibitor 65 systemic ALCL 65 sorafenib Nexavar ® 65 Technosphere Insulin 65 pharmacodynamic profile 65 mitogen activated ERK kinase 65 pharmacokinetic interactions 65 telbivudine 65 relapsing multiple sclerosis 65 raltegravir 65 systemic RNAi therapeutic 65 IMiDs ® 65 Metastatic Melanoma 65 interferon beta therapy 65 XOMA 3AB 65 orBec 65 Fludara ® 65 Anturol TM 65 Azedra ™ 65 serum phosphate 65 dexanabinol 65 KSP inhibitor 65 #D#C# 65 Clavis Pharma 65 PF # [001] 65 trastuzumab Herceptin ® 65 TREDAPTIVE 65 BENLYSTA ® 65 Cloretazine R 65 DCVax R 65 NSABP C 64 solithromycin 64 AMEVIVE 64 RhuDex R 64 ONCONASE